Implant Files was the first global investigation into the medical device industry that tracked the harm caused by medical devices that have been tested inadequately or not at all.
An oversight initiative meant to help officials detect medical device safety issues has faltered due to patchy recordkeeping by health care professionals.
ICIJ’s Implant Files uncovered controversial deals between Medtronic and hospitals around the world. Now, a former U.S. sales representative alleges the company used kickbacks and pressure tactics to make sales, despite patient injuries.
After testimonies by Julie Elliott and other patient advocates last month, Canadian officials recommended health regulators create a breast implant registry “as soon as possible.”
ICIJ member Jet Schouten kicked off the 2018 project with her reporting on lax regulation in the Netherlands. Since then, reporting on medical devices has only become more difficult.
The ICIJ-led investigation exposed serious flaws in the multi-billion-dollar global medical device industry, including patchwork regulation and oversight gaps worldwide.
Florida company Stimwave and its CEO duped doctors into implanting useless pieces of plastic into chronic pain patients.
Reporter Boyoung Lim originally started her career as an officer on the Korean police force, before realizing there were other ways to help people pursue justice and hold the powerful to account.
The new research appears to corroborate a key finding from the Implant Files investigation, which showed revealed how deaths linked to medical devices were being underreported.
The rare ‘fraud alert’ from the Department of Health and Human Services could signal a harder line on industry-funded speaker programs.
The research challenges the claim that patient care decisions are not influenced when physicians receive large payments from drug and medical device companies.
The ruling excluded information on the grounds of protecting trade secrets as Le Monde journalists continue to call for press freedom.
The new FDA guideline is meant to alert patients to the health risks of breast implants, which have been associated with serious illnesses, ICIJ’s Implant Files investigation found.
Frustrated by FDA delays, some survivors are promoting laws to require informed consent before breast implant surgery in at least six states.
An ICIJ member since 2001, Dutch investigative journalist Joop Bouma knows about the power of collaborations – we spoke with him as he wrapped up a career spanning more than 45 years.
Tens of thousands of women claimed they suffered severe health problems after being implanted with the contraceptive device.
Only a fraction of incidents in which women were allegedly harmed by the contraceptive device were reported, experts in California cases claim.
A new study in a leading plastic surgery journal offers more evidence to support the existence of breast implant illness.
Public Citizen finds the U.S. health watchdog putting patients at risk by not requiring human trials for all new versions of the implant.
US health authorities have issued a warning letter to leading global manufacturer, Allergan, for failing to properly carry post-market safety studies.
A controversial therapy for children with curved spines that featured in the Implant Files investigation has been banned in the United Kingdom.
The FDA won’t release data about whether patients were female or male, so ICIJ joined forces with Stanford to find answers.
The International Medical Device Database now has more than 120,000 records about faulty or even dangerous medical devices from 46 countries.
Hundreds of Australian women who suffered from a controversial type of transvaginal mesh won a landmark class action lawsuit against Johnson & Johnson.
ICIJ received more than 3,500 responses from people affected by the medical device industry in 50 countries, bringing to life the personal cost of implants that fail.
Patients who suffered debilitating immune reactions after being implanted with metal-containing devices have joined doctors, scientists and industry representatives to testify before a United States government advisory panel.